![Gregory Davis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 24 777 $ al 31/05/2026
Gregory Davis is currently Head-Research & Technology at Sangamo Therapeutics, Inc. since 2020.
Formerly, Dr. Davis was Head-Genome Engineering at Sigma-Aldrich, Inc. Education includes a doctorate from the University of Oklahoma and an undergraduate degree from the University of Texas at Austin.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/05/2026 | 113.654 ( 0,03 % ) | 24 777 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 17/11/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Sigma-Aldrich, Inc.
 Sigma-Aldrich, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures chemicals and chemical preparations | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Sigma-Aldrich, Inc.
Sigma-Aldrich, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures chemicals and chemical preparations | Process Industries |
University of Oklahoma
 University of Oklahoma Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Texas at Austin
 University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
